![](https://www.diabetesnews.com/wp-content/uploads/2014/09/row-of-black-and-white-pills-schedivy-pictures-inc-150x150.jpg)
Metformin is the first-line drug treatment for type 2 diabetes, but in some patients, the drug’s effectiveness can decline over time. A clinical trial has found that a combination of two newer diabetes drugs, exenatide and dapagliflozin, is effective in patients whose blood glucose levels did not respond to metformin. Read more